By InvitationNot Applicable

Okami Medical ALPHA Registry

United States500 participantsStarted 2026-03-31

Plain-language summary

This registry will provide insights into the use of Okami Medical devices in real-world clinical and study effectiveness and safety of Okami Medical devices.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient or their legally authorized representative is willing and able to provide informed consent per local requirements * Has or will receive treatment with an eligible Okami Medical device * Age ≥ 18 years Exclusion Criteria: * Is or will be inaccessible for registry follow-up * Meets exclusion criteria required by local requirements * Current or planned participation in a drug or device study that would interfere with participation in this registry or confound the results of this registry in the opinion of the investigator

What they're measuring

Safety Endpoint

Timeframe: 30 days post-index procedure

Effectiveness Endpoint

Timeframe: During index procedure

Trial details

NCT IDNCT07525518

SponsorOkami Medical, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2030-08

View on ClinicalTrials.gov More Arterial Bleed trials